{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:59:17Z","timestamp":1790272757543,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL143074"],"award-info":[{"award-number":["1R01HL143074"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL133290"],"award-info":[{"award-number":["R01HL133290"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bbadis.2023.166724","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T21:24:57Z","timestamp":1682198697000},"page":"166724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit"],"prefix":"10.1016","volume":"1869","author":[{"given":"Prachi","family":"Umbarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulivette Y.","family":"Ruiz Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Toro Cora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Tousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166724_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0010","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2023.166724_bb0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO J."},{"issue":"Pt 3","key":"10.1016\/j.bbadis.2023.166724_bb0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166724_bb0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.1156037","article-title":"Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation","volume":"320","author":"Thornton","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2023.166724_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-010-0544-0","article-title":"Regulation of GSK3 isoforms by phosphatases PP1 and PP2A","volume":"344","author":"Hernandez","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2006.10.009","article-title":"A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation","volume":"24","author":"Lochhead","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2023.166724_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/bbrc.2001.4986","article-title":"Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2","volume":"284","author":"Hartigan","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2023.166724_bb0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","article-title":"Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and fyn tyrosine kinase","volume":"72","author":"Lesort","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0050","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.M110.127969","article-title":"Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium\/calpain signaling","volume":"286","author":"Azoulay-Alfaguter","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.yjmcc.2007.08.010","article-title":"Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection","volume":"43","author":"Nishihara","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0060","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","article-title":"Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain","volume":"93","author":"Hoshi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166724_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/oxfordjournals.jbchem.a124965","article-title":"Different localization of tau protein kinase I\/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria","volume":"118","author":"Hoshi","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0070","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2023.166724_bb0075","doi-asserted-by":"crossref","first-page":"37436","DOI":"10.1074\/jbc.M105725200","article-title":"Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta","volume":"276","author":"Bijur","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.423","article-title":"Regulation of ER stress-induced autophagy by GSK3beta-TIP60-ULK1 pathway","volume":"7","author":"Nie","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2023.166724_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/ATVBAHA.111.237941","article-title":"Endoplasmic reticulum stress and glycogen synthase kinase-3beta activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis","volume":"32","author":"McAlpine","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0090","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.yexcr.2011.02.012","article-title":"Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells","volume":"317","author":"Meares","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001731","article-title":"ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor","volume":"4","author":"Chen","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2023.166724_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/jcs.01562","article-title":"Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3","volume":"118","author":"Kim","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2023.166724_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1101\/gad.1165804","article-title":"Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta","volume":"18","author":"Qu","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2023.166724_bb0110","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"277","author":"Song","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0115","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1159\/000485580","article-title":"The key roles of GSK-3beta in regulating mitochondrial activity","volume":"44","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fonc.2013.00016","article-title":"GSK-3 and mitochondria in cancer cells","volume":"3","author":"Chiara","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03033861","article-title":"Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency","volume":"14","author":"King","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1101\/gad.1624208","article-title":"SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis","volume":"22","author":"Olson","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2023.166724_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1474-9726.2007.00357.x","article-title":"Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response","volume":"7","author":"Anderson","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2023.166724_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005491","article-title":"Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP\/MPP-treated neurons","volume":"4","author":"Petit-Paitel","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166724_bb0145","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"Juhaszova","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166724_bb0150","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10557.1","article-title":"Recent advances in understanding the cellular roles of GSK-3","volume":"6","author":"Cormier","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.bbadis.2023.166724_bb0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2023.166724_bb0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","article-title":"Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies","volume":"152","author":"Muntane","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2023.166724_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbadis.2023.166724_bb0170","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2174\/1389450110607011389","article-title":"Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease","volume":"7","author":"Huang","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbadis.2023.166724_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2023.166724_bb0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","article-title":"Glycogen synthase kinase 3: an emerging therapeutic target","volume":"8","author":"Eldar-Finkelman","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2023.166724_bb0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbadis.2023.166724_bb0190","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0200","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166724_bb0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2017.03.001","article-title":"Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps","volume":"38","author":"Ma","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2023.166724_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092412","article-title":"Mechanisms of fibroblast activation and myocardial fibrosis: lessons Learned from FB-specific conditional mouse models","volume":"10","author":"Umbarkar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166724_bb0220","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2023.166724_bb0225","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1242\/dev.079970","article-title":"The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors","volume":"139","author":"Acharya","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2023.166724_bb0230","doi-asserted-by":"crossref","first-page":"33181","DOI":"10.1074\/jbc.M705133200","article-title":"Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases","volume":"282","author":"Zhai","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3alpha promotes fibrosis via RAF-MEK-ERK pathway in the injured heart","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0240","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/MCB.00586-15","article-title":"SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3beta","volume":"36","author":"Sundaresan","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0245","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1091\/mbc.e11-04-0335","article-title":"Beta-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition","volume":"22","author":"Charbonney","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2023.166724_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2010.06.042","article-title":"Glycogen synthase kinase-3beta negatively regulates TGF-beta1 and angiotensin II-mediated cellular activity through interaction with Smad3","volume":"644","author":"Hua","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1101\/gad.1590908","article-title":"Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling","volume":"22","author":"Guo","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2023.166724_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.113.008364","article-title":"Cardiac fibroblast glycogen synthase kinase-3beta regulates ventricular remodeling and dysfunction in ischemic heart","volume":"130","author":"Lal","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2023.166724_bb0265","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI41407","article-title":"GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice","volume":"120","author":"Zhou","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166724_bb0270","doi-asserted-by":"crossref","first-page":"20900","DOI":"10.1073\/pnas.0808315106","article-title":"Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload","volume":"105","author":"Matsuda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166724_bb0275","doi-asserted-by":"crossref","first-page":"H979","DOI":"10.1152\/ajpheart.00415.2012","article-title":"Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3alpha during aging and hemodynamic pressure overload","volume":"303","author":"Maejima","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0280","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jacc.2014.04.068","article-title":"Cardiomyocyte-specific deletion of Gsk3alpha mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure","volume":"64","author":"Ahmad","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yjmcc.2019.03.020","article-title":"Cardiomyocyte-GSK-3alpha promotes mPTP opening and heart failure in mice with chronic pressure overload","volume":"130","author":"Ahmad","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","article-title":"Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy","volume":"151","author":"Haq","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0295","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1074\/jbc.275.19.14466","article-title":"The akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes","volume":"275","author":"Morisco","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0300","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.0000184684.88750.FE","article-title":"Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation","volume":"97","author":"Badorff","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0305","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.RES.0000124977.59827.80","article-title":"Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy","volume":"94","author":"Hardt","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0310","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.0835895100","article-title":"Stabilization of beta-catenin by a wnt-independent mechanism regulates cardiomyocyte growth","volume":"100","author":"Haq","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166724_bb0315","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cvr\/cvaa298","article-title":"Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure","volume":"117","author":"Nakamura","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413586","article-title":"GSK3beta serine 389 phosphorylation modulates cardiomyocyte hypertrophy and ischemic injury","volume":"22","author":"Vainio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166724_bb0325","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166724_bb0330","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.107.160614","article-title":"Inhibition of glycogen synthase kinase 3beta during heart failure is protective","volume":"101","author":"Hirotani","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0335","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCRESAHA.109.211482","article-title":"Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo","volume":"106","author":"Woulfe","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2020.09.009","article-title":"Glycogen synthase kinase-3beta inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction","volume":"149","author":"Wang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0345","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jcp.30644","article-title":"Cardiomyocyte-GSK-3beta deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms","volume":"237","author":"Yusuf","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0350","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.111.249532","article-title":"Differential roles of GSK-3beta during myocardial ischemia and ischemia\/reperfusion","volume":"109","author":"Zhai","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0355","article-title":"Ser9 phosphorylation of GSK-3beta promotes aging in the heart through suppression of autophagy","volume":"1","author":"Chen","year":"2021","journal-title":"J. Cardiovasc. Aging"},{"key":"10.1016\/j.bbadis.2023.166724_bb0360","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCRESAHA.116.307474","article-title":"Aging and autophagy in the heart","volume":"118","author":"Shirakabe","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI69253","article-title":"Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3beta","volume":"124","author":"Kirk","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166724_bb0370","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.112.275602","article-title":"GSK3beta phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication","volume":"112","author":"Kuster","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0375","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCRESAHA.121.319491","article-title":"GSK-3beta localizes to the cardiac Z-disc to maintain length dependent activation","volume":"130","author":"Stachowski-Doll","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0380","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbadis.2023.166724_bb0385","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40256-014-0089-9","article-title":"The cardioprotection of the insulin-mediated PI3K\/Akt\/mTOR signaling pathway","volume":"14","author":"Yao","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.bbadis.2023.166724_bb0390","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/14728222.12.10.1265","article-title":"Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes","volume":"12","author":"MacAulay","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbadis.2023.166724_bb0395","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/JOE-09-0456","article-title":"Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1","volume":"206","author":"Leng","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0400","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1074\/jbc.M410610200","article-title":"Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling","volume":"280","author":"Liberman","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166724_bb0405","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/diabetes.51.7.2190","article-title":"Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle","volume":"51","author":"Nikoulina","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2023.166724_bb0410","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/diabetes.51.10.2903","article-title":"Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in zucker diabetic fatty (fa\/fa) rats","volume":"51","author":"Cline","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2023.166724_bb0415","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2023.166724_bb0420","doi-asserted-by":"crossref","first-page":"E892","DOI":"10.1152\/ajpendo.00346.2002","article-title":"Modulation of muscle insulin resistance by selective inhibition of GSK-3 in zucker diabetic fatty rats","volume":"284","author":"Henriksen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0425","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1152\/ajpendo.00547.2004","article-title":"Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle","volume":"288","author":"Dokken","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0430","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.105.090266","article-title":"Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob\/ob mice: molecular characterization in liver and muscle","volume":"316","author":"Kaidanovich-Beilin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2023.166724_bb0435","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.00628.2005","article-title":"Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese zucker rats","volume":"291","author":"Dokken","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0440","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00125-006-0552-5","article-title":"Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL\/6J mice","volume":"50","author":"Rao","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2023.166724_bb0445","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/BJ20120834","article-title":"Hypothalamic glycogen synthase kinase 3beta has a central role in the regulation of food intake and glucose metabolism","volume":"447","author":"Benzler","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166724_bb0450","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s10495-014-1037-5","article-title":"Enhanced glycogen synthase kinase-3beta activity mediates podocyte apoptosis under diabetic conditions","volume":"19","author":"Paeng","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbadis.2023.166724_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.03.011","article-title":"Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3beta inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance","volume":"409","author":"Kim","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0460","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10557-013-6467-8","article-title":"The consequences of long-term glycogen synthase kinase-3 inhibition on normal and insulin resistant rat hearts","volume":"27","author":"Flepisi","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbadis.2023.166724_bb0465","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.metabol.2004.05.008","article-title":"Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter","volume":"53","author":"Pearce","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2023.166724_bb0470","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/j.febslet.2005.05.040","article-title":"Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart","volume":"579","author":"Mora","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2023.166724_bb0475","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2007.08.013","article-title":"Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism","volume":"6","author":"MacAulay","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0480","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1152\/ajpendo.00481.2007","article-title":"Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle","volume":"294","author":"Bouskila","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0485","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00125-007-0914-7","article-title":"Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation","volume":"51","author":"Liu","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2023.166724_bb0490","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1128\/MCB.00763-08","article-title":"Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action","volume":"28","author":"Patel","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0495","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s00125-010-1882-x","article-title":"Conditional ablation of gsk-3beta in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice","volume":"53","author":"Liu","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2023.166724_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015845","article-title":"Tissue-specific analysis of glycogen synthase kinase-3alpha (GSK-3alpha) in glucose metabolism: effect of strain variation","volume":"6","author":"Patel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166724_bb0505","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1210\/en.2013-1155","article-title":"GSK-3beta function in bone regulates skeletal development, whole-body metabolism, and male life span","volume":"154","author":"Gillespie","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2023.166724_bb0510","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1073\/pnas.1601355113","article-title":"PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166724_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2018.01.013","article-title":"Cardiomyocyte-specific deletion of GSK-3beta leads to cardiac dysfunction in a diet induced obesity model","volume":"259","author":"Gupte","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0520","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cmet.2019.01.005","article-title":"Glycogen synthase kinase-3alpha promotes fatty acid uptake and lipotoxic cardiomyopathy","volume":"29","author":"Nakamura","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2023.166724_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051120","article-title":"Deletion of cardiomyocyte glycogen synthase Kinase-3 Beta (GSK-3beta) improves systemic glucose tolerance with maintained heart function in established obesity","volume":"9","author":"Gupte","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166724_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030559","article-title":"Isoform-specific role of GSK-3 in high fat diet induced obesity and glucose intolerance","volume":"11","author":"Gupte","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166724_bb0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jelectrocard.2004.10.004","article-title":"Lithium concentration correlates with QTc in patients with psychosis","volume":"38","author":"Mamiya","year":"2005","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.bbadis.2023.166724_bb0540","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/hrt.70.4.371","article-title":"Sinus node dysfunction during long-term lithium treatment","volume":"70","author":"Rosenqvist","year":"1993","journal-title":"Br. Heart J."},{"key":"10.1016\/j.bbadis.2023.166724_bb0545","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.0954-6820.1984.tb03777.x","article-title":"ECG changes during lithium therapy. A prospective study","volume":"216","author":"Bucht","year":"1984","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.bbadis.2023.166724_bb0550","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM197605272942209","article-title":"Reversible sinus-node abnormalities due to lithium carbonate therapy","volume":"294","author":"Wilson","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2023.166724_bb0555","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(75)90365-4","article-title":"Symptomatic sinus node abnormalities following lithium carbonate therapy","volume":"59","author":"Wellens","year":"1975","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2023.166724_bb0560","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam8572","article-title":"Selective inhibition of glycogen synthase kinase 3alpha corrects pathophysiology in a mouse model of fragile X syndrome","volume":"12","author":"McCamphill","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166724_bb0565","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cvr\/cvz061","article-title":"Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors","volume":"115","author":"Nikolaou","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2023.166724_bb0570","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam8460","article-title":"Exploiting an asp-glu \"switch\" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia","volume":"10","author":"Wagner","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T21:59:52Z","timestamp":1722549592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392300090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S092544392300090X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166724","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166724"}}